-
GenAI drug discovery firm Insilico raises $123m as it eyes Hong Kong IPO
16 Jun 2025 11:47 GMT
… cities of Shanghai and Wuxi are also among Insilico’ … after Insilico filed for an initial public offering (IPO) in Hong Kong after … out-licensed to international pharmaceutical and healthcare companies with … and Chinese biopharmaceutical company WuXi AppTec.
-
Wuxi XDC Received Multiple Awards From 2025 Extel (Previously Institutional Investor) Ranking In Diverse Categories
20 May 2025 02:47 GMT
… was named "Best IPO" by IFR Asia … quot;, "Most Valuable Pharmaceutical and Healthcare Company", … Pharmaceutical Listed Companies in ESG Competitiveness 2024".
In 2024, WuXi … of top 20 global pharmaceutical companies have partnered with …
-
WuXi Group Wrestles With Uncertainty Over Pharma Tariffs
17 Apr 2025 15:06 GMT
… punitive actions specifically targeting pharmaceutical products is hard to … services for the global pharmaceutical sector. The statement said … the company's IPO in November 2023.
That …
Like many Chinese companies, WuXi XDC has been offshoring production …
-
HUHUTECH International Group Inc. Announces Closing of Initial Public Offering
23 Oct 2024 20:30 GMT
Wuxi, China, Oct. 23, 2024 (GLOBE … announced the closing of its initial public offering (the “Offering”) of 1,050 … system in the Company’s Wuxi plant; (ii) the expansion and … factories, as well as some pharmaceutical, food and beverage manufacturers. For …
-
HUHUTECH International Group Inc. Announces Pricing of Initial Public Offering
21 Oct 2024 22:00 GMT
Wuxi, China, Oct. 21, 2024 (GLOBE … announced the pricing of its initial public offering (the “Offering”) of 1,050 … system in the Company’s Wuxi plant; (ii) the expansion and … factories, as well as some pharmaceutical, food and beverage manufacturers. For …
-
Fierce Pharma Asia—Novo's triple G obesity bet; Merck's latest China deal; Hengrui, Elevar's 2nd FDA snub
28 Mar 2025 17:50 GMT
… ) inhibitor from Jiangsu Hengrui Pharma for cardiovascular disease. Hengrui … last year. The Illinois pharma alleged that Genmab was “ … 2027 year
9. Contractors WuXi Bio, WuXi XDC eye continued growth … in China files $86M IPO
15. Bharat Biotech enters …
-
Fierce Pharma Asia—Takeda R&D chief's new strategy; AZ, Daiichi's ADC nod; Fosun's failed Henlius buy
24 Jan 2025 20:54 GMT
… majority shareholder Fosun Pharma’s take-private proposal. … China’s Ascentage Pharma filed for an IPO on the Nasdaq … Biokin Pharmaceutical and Shanghai Bao Pharmaceuticals, filed for Hong Kong IPOs.
5 … its Advanced Therapies unit, WuXi AppTec has decided to …
-
Fierce Pharma Asia—A $410M obesity debut; Another Roche ADC deal; Legend, BeiGene as buyout targets?
10 Jan 2025 16:17 GMT
… ’s Japanese unit Chugai Pharmaceutical is teaming up with … vaccines plant from CDMO WuXi Biologics
WuXi Biologics has decided to … preclinical trispecific candidate from WuXi Biologics. The company is … Biosciences files for $397M IPO amid expansion efforts
11. …
-
HUHUTECH International Aims For U.S. IPO At Ultra-High Valuation
04 Sep 2024 18:30 GMT
… factories, as well as some pharmaceutical, food and beverage manufacturers.… gas supply system in our Wuxi plant; approximately 30% of … seeking a U.S. IPO. Regarding outstanding legal proceedings, … , aiming their IPOs at retail investors. Post-IPO, the vast …
-
Ascentage Pharma Announces 2024 Interim Results
22 Aug 2024 17:09 GMT
… Inner Mongolia Autonomous Region, Wuxi, Huzhou, Shenzhen, and Yantai, … initial public offering of American depositary shares (ADSs) representing its ordinary shares. Ascentage Pharma … investors." About Ascentage Pharma Ascentage Pharma (6855.HK) is a …